Emerging domestic natural gas and helium producer Renergen has developed a new device, the Renergen Cryo-Vacc, which is said to simplify the logistics of moving vaccines at temperatures of between -70 °C and -150 °C for periods of up to 30 days, regardless of ambient conditions, without the need for any power supply. The company has filed for the patent rights to its design and is calling on collaborators to use the design in the large-scale manufacture of these devices, to assist in the deployment of ultra-low temperature vaccines, such as the recently announced Pfizer Covid-19 vaccine.
from Engineering News | Home https://ift.tt/3mZ6luV
